Literature DB >> 15844069

Is it time to abandon the use of amphotericin B bladder irrigation?

Richard H Drew1, Rebekah R Arthur, John R Perfect.   

Abstract

In this article, we review the issues surrounding funguria and its management. With this background, the value of bladder irrigation with amphotericin B for the management of funguria is directly examined. Amphotericin B bladder irrigation is used frequently in clinical practice. Although its use is not standardized, there are multiple studies that attempt to show the impact on funguria management. These bladder irrigations have been used either for treatment of funguria or (less commonly) as a diagnostic test in attempts to identify upper urinary tract disease. Despite their widespread therapeutic use and relative safety, it is not clear from our experience and a review of the literature that amphotericin B bladder irrigations have any diagnostic or therapeutic value. The patient may be best served by removal of the urinary catheter, if possible, rather than by instillation of bladder irrigation with amphotericin B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844069     DOI: 10.1086/429722

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Localised fungal infection in a prosthetic mesh treated conservatively.

Authors:  Mehwash Nadeem; Hasnain Zafar; Muhammad Shahrukh Effendi
Journal:  BMJ Case Rep       Date:  2011-02-02

2.  [Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis].

Authors:  Yuan-Yuan Xiang; Yu Lv; Ren Guo; Juan Xue
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

Review 3.  [Diagnostics and therapy for invasive fungal infections in an intensive care unit].

Authors:  S Koch; H Haefner; F Huenger; G Haase; J Wildberger; S W Lemmen
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

Review 4.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Fungus ball and emphysematous cystitis secondary to Candida tropicalis: A case report.

Authors:  Lei Wang; Xiang Ji; Guo-Feng Sun; Ying-Chao Qin; Miao-Zi Gong; Jin-Xia Zhang; Ning-Chen Li; Yan-Qun Na
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

Review 6.  Invasive fungal infections in patients with cancer in the Intensive Care Unit.

Authors:  Nikolaos V Sipsas; Dimitrios P Kontoyiannis
Journal:  Int J Antimicrob Agents       Date:  2012-02-14       Impact factor: 5.283

7.  In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract.

Authors:  Frieder Fuchs; Alexander Maximilian Aldejohann; Ada Marie Hoffmann; Grit Walther; Oliver Kurzai; Axel G Hamprecht
Journal:  Antimicrob Agents Chemother       Date:  2022-05-11       Impact factor: 5.938

8.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

9.  Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria.

Authors:  Mark J Biagi; Nathan P Wiederhold; Connie Gibas; Brian L Wickes; Victoria Lozano; Susan C Bleasdale; Larry Danziger
Journal:  Open Forum Infect Dis       Date:  2019-06-01       Impact factor: 3.835

Review 10.  Candida auris Urinary Tract Infections and Possible Treatment.

Authors:  Nicole Griffith; Larry Danziger
Journal:  Antibiotics (Basel)       Date:  2020-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.